Though COCP is recommended for use in guidenlines(evidence level II), is it because the data form studies is varied, the answer is false?
For spitonolactone, there is a RCT(Ib) which showed significantly greater improvement in both somatic and mood symptoms, then why false?
Acta Obstet Gynaecol Scand 1995; 74:803